当前位置:
X-MOL 学术
›
Curr. Opin. Otolaryngol. Head Neck Surg.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The added value of radiomics in determining patient responsiveness to laryngeal preservation strategies.
Current Opinion in Otolaryngology & Head and Neck Surgery ( IF 1.9 ) Pub Date : 2024-01-19 , DOI: 10.1097/moo.0000000000000963 Marco Ravanelli 1 , Paolo Rondi , Nunzia Di Meo , Davide Farina
Current Opinion in Otolaryngology & Head and Neck Surgery ( IF 1.9 ) Pub Date : 2024-01-19 , DOI: 10.1097/moo.0000000000000963 Marco Ravanelli 1 , Paolo Rondi , Nunzia Di Meo , Davide Farina
Affiliation
Laryngeal cancer (LC) is a highly aggressive malignancy of the head and neck and represents about 1-2% of cancer worldwide.Treatment strategies for LC aim both to complete cancer removal and to preserve laryngeal function or maximize larynx retention.Predicting with high precision response to induction chemotherapy (IC) is one of the main fields of research when considering LC, since this could guide treatment strategies in locally advanced LC.
中文翻译:
放射组学在确定患者对喉部保存策略的反应方面的附加值。
喉癌 (LC) 是一种高度侵袭性的头颈部恶性肿瘤,约占全球癌症的 1-2%。 LC 的治疗策略旨在完成癌症切除并保留喉功能或最大限度地保留喉部。高精度预测在考虑 LC 时,诱导化疗 (IC) 的反应是主要研究领域之一,因为这可以指导局部晚期 LC 的治疗策略。
更新日期:2024-01-19
中文翻译:
放射组学在确定患者对喉部保存策略的反应方面的附加值。
喉癌 (LC) 是一种高度侵袭性的头颈部恶性肿瘤,约占全球癌症的 1-2%。 LC 的治疗策略旨在完成癌症切除并保留喉功能或最大限度地保留喉部。高精度预测在考虑 LC 时,诱导化疗 (IC) 的反应是主要研究领域之一,因为这可以指导局部晚期 LC 的治疗策略。